Literature DB >> 15105099

The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in african trypanosomes.

Harry P de Koning1, Laura F Anderson, Mhairi Stewart, Richard J S Burchmore, Lynsey J M Wallace, Michael P Barrett.   

Abstract

Resistance to diminazene aceturate (Berenil) is a severe problem in the control of African trypanosomiasis in domestic animals. It has been speculated that resistance may be the result of reduced diminazene uptake by the parasite. We describe here the mechanisms by which [(3)H]diminazene is transported by Trypanosoma brucei brucei bloodstream forms. Diminazene was rapidly accumulated through a single transporter, with a K(m) of 0.45 +/- 0.11 micro M, which was dose dependently inhibited by pentamidine and adenosine. The K(i) values for these inhibitors were consistent with this transporter being the P2/TbAT1 adenosine transporter. Yeast expressing TbAT1 acquired the ability to take up [(3)H]diminazene and [(3)H]pentamidine. TbAT1-null mutants had lost almost all capacity for [(3)H]diminazene transport. However, this cell line still displayed a small but detectable rate of [(3)H]diminazene accumulation, in a nonsaturable manner. We conclude that TbAT1 mediates [(3)H]diminazene transport almost exclusively and that this explains the observed diminazene resistance phenotypes of TbAT1-null mutants and field isolates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105099      PMCID: PMC400564          DOI: 10.1128/AAC.48.5.1515-1519.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  African bovine trypanosomiasis: the problem of drug resistance.

Authors:  S Geerts; P H Holmes; M C Eisler; O Diall
Journal:  Trends Parasitol       Date:  2001-01

Review 2.  Drug resistance in pathogenic African trypanosomes: what hopes for the future?

Authors:  B M Anene; D N Onah; Y Nawa
Journal:  Vet Parasitol       Date:  2001-03-20       Impact factor: 2.738

Review 3.  The situation of sleeping sickness in Angola: a calamity.

Authors:  A Stanghellini; T Josenando
Journal:  Trop Med Int Health       Date:  2001-05       Impact factor: 2.622

4.  A nucleoside transporter from Trypanosoma brucei involved in drug resistance.

Authors:  P Mäser; C Sütterlin; A Kralli; R Kaminsky
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

5.  Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy.

Authors:  E Matovu; F Geiser; V Schneider; P Mäser; J C Enyaru; R Kaminsky; S Gallati; T Seebeck
Journal:  Mol Biochem Parasitol       Date:  2001-09-28       Impact factor: 1.759

6.  Arsenical-resistant trypanosomes lack an unusual adenosine transporter.

Authors:  N S Carter; A H Fairlamb
Journal:  Nature       Date:  1993-01-14       Impact factor: 49.962

Review 7.  The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes.

Authors:  M P Barrett; A H Fairlamb
Journal:  Parasitol Today       Date:  1999-04

8.  Changes in properties of adenosine transporters in Trypanosoma evansi and modes of selection of resistance to the melaminophenyl arsenical drug, Mel Cy.

Authors:  E A Suswam; D W Taylor; C A Ross; R J Martin
Journal:  Vet Parasitol       Date:  2001-12-13       Impact factor: 2.738

9.  The phenomenon of treatment failures in Human African Trypanosomiasis.

Authors:  R Brun; R Schumacher; C Schmid; C Kunz; C Burri
Journal:  Trop Med Int Health       Date:  2001-11       Impact factor: 2.622

10.  Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.

Authors:  Enock Matovu; Mhairi L Stewart; Federico Geiser; Reto Brun; Pascal Mäser; Lynsey J M Wallace; Richard J Burchmore; John C K Enyaru; Michael P Barrett; Ronald Kaminsky; Thomas Seebeck; Harry P de Koning
Journal:  Eukaryot Cell       Date:  2003-10
View more
  44 in total

1.  Symmetrical choline-derived dications display strong anti-kinetoplastid activity.

Authors:  Hasan M S Ibrahim; Mohammed I Al-Salabi; Nasser El Sabbagh; Neils B Quashie; Abdulsalam A M Alkhaldi; Roger Escale; Terry K Smith; Henri J Vial; Harry P de Koning
Journal:  J Antimicrob Chemother       Date:  2010-11-14       Impact factor: 5.790

2.  Accumulation and intracellular distribution of antitrypanosomal diamidine compounds DB75 and DB820 in African trypanosomes.

Authors:  Amanda M Mathis; Jacqueline L Holman; Lisa M Sturk; Mohamed A Ismail; David W Boykin; Richard R Tidwell; James Edwin Hall
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Interaction of monobenzamidine-linked trypanocides with the Trypanosoma brucei P2 aminopurine transporter.

Authors:  Mhairi L Stewart; Cyrille Boussard; Reto Brun; Ian H Gilbert; Michael P Barrett
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

4.  Synthesis of marine-derived 3-alkylpyridinium alkaloids with potent antiprotozoal activity.

Authors:  Boris Rodenko; Mohammed I Al-Salabi; Ibrahim A Teka; William Ho; Nasser El-Sabbagh; Juma A M Ali; Hasan M S Ibrahim; Martin J Wanner; Gerrit-Jan Koomen; Harry P de Koning
Journal:  ACS Med Chem Lett       Date:  2011-10-05       Impact factor: 4.345

5.  9-(2'-Deoxy-2'-Fluoro-β-d-Arabinofuranosyl) Adenine Is a Potent Antitrypanosomal Adenosine Analogue That Circumvents Transport-Related Drug Resistance.

Authors:  Farahnaz Ranjbarian; Munender Vodnala; Khalid J H Alzahrani; Godwin U Ebiloma; Harry P de Koning; Anders Hofer
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

6.  Multiple genetic mechanisms lead to loss of functional TbAT1 expression in drug-resistant trypanosomes.

Authors:  Mhairi L Stewart; Richard J S Burchmore; Caroline Clucas; Christiane Hertz-Fowler; Karen Brooks; A Tait; A Macleod; C Michael R Turner; Harry P De Koning; Pui Ee Wong; Michael P Barrett
Journal:  Eukaryot Cell       Date:  2009-12-04

7.  Rapid identification of isometamidium-resistant stocks of Trypanosoma b. brucei by PCR-RFLP.

Authors:  Yohannes Afework; Pascal Mäser; Benjamin Etschmann; Georg von Samson-Himmelstjerna; Karl-Hans Zessin; Peter-Henning Clausen
Journal:  Parasitol Res       Date:  2006-03-16       Impact factor: 2.289

Review 8.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

9.  Preclinical assessment of the treatment of second-stage African trypanosomiasis with cordycepin and deoxycoformycin.

Authors:  Suman K Vodnala; Marcela Ferella; Hilda Lundén-Miguel; Evans Betha; Nick van Reet; Daniel Ndem Amin; Bo Oberg; Björn Andersson; Krister Kristensson; Hans Wigzell; Martin E Rottenberg
Journal:  PLoS Negl Trop Dis       Date:  2009-08-04

10.  Genotypic status of the TbAT1/P2 adenosine transporter of Trypanosoma brucei gambiense isolates from Northwestern Uganda following melarsoprol withdrawal.

Authors:  Anne J N Kazibwe; Barbara Nerima; Harry P de Koning; Pascal Mäser; Michael P Barrett; Enock Matovu
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.